Strength of prior stimuli determines the magnitude of secondary responsiveness in CD8+ T cells

Cellular Immunology

Volumn 217, Issue 1-2, 2002, Pages 36-46

  Lim, Dong Gyun ^a   Höllsberg, Per ^b   Hafler, David A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Anergy; CD8+ T lymphocyte; Cellular proliferation; Cytokine

Indexed keywords

CD2 ANTIGEN; CD8 ANTIGEN; LIGAND; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; PEPTIDE;

ARTICLE; CELL DIVISION; CLONAL ANERGY; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGENS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; CHO CELLS; CLONAL ANERGY; CLONE CELLS; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION;

EID: 0036433099     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-8749(02)00511-7     Document Type: Article

References (39)

1. R.H. Schwartz, Models of T cell anergy: Is there a common molecular mechanism?, J. Exp. Med. 184 (1996) 1-8.
2. M.K. Jenkins, R.H. Schwartz, Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo, J. Exp. Med. 165 (1987) 302-319.
3. H. Quill, R.H. Schwartz, Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: Specific induction of a long-lived state of proliferative nonresponsiveness, J. Immunol. 138 (1987) 3704-3712.
4. F.A. Harding, J.G. McArthur, J.A. Gross, D.H. Raulet, J.P. Allison, CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones, Nature 356 (1992) 607-609.
5. J. Sloan-Lancaster, B.D. Evavold, P.M. Allen, Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells, Nature 363 (1993) 156-159.
6. L.C. Korb, S. Mirshahidi, K. Ramyar, A.A. Sadighi Akha, S. Sadegh-Nasseri, Induction of T cell anergy by low numbers of agonist ligands, J. Immunol. 162 (1999) 6401-6409.
7. M.K. Jenkins, The role of cell division in the induction of clonal anergy, Immunol. Today 13 (1992) 69-73.
8. B. Beverly, S.M. Kang, M.J. Lenardo, R.H. Schwartz, Reversal of in vitro T cell clonal anergy by IL-2 stimulation, Int. Immunol. 4 (1992) 661-671.
9. H. Quill, Anergy as a mechanism of peripheral T cell tolerance, J. Immunol. 156 (1996) 1325-1327.
10. L.S. Taams, W.V. Eden, M.H.M. Wauben, Dose-dependent induction of distinct anergic phenotypes: Multiple levels of T cell anergy, J. Immunol. 162 (1999) 1974-1981.
11. G.R. Otten, R.N. Germain, Split anergy in a CD8+ T cell: Receptor-dependent cytolysis in the absence of interleukin-2 production, Science 251 (1991) 1228-1231.
12. P. Hollsberg, V. Batra, A. Dressel, D.A. Hafler, Induction of anergy in CD8 T cells by B cell presentation of antigen, J. Immunol. 157 (1996) 5269-5276.
13. J.-G. Chai, I. Bartok, D. Scott, J. Dyson, R. Lechler, T:T antigen presentation by activated murine CD8+ T cells induces anergy and apoptosis, J. Immunol. 160 (1998) 3655-3665.
14. M.J. Deeths, R.M. Kedl, M.F. Mescher, CD8+ T cells become nonresponsive (anergic) following activation in the presence of costimulation, J. Immunol. 163 (1999) 102-110.
15. P. Hollsberg, W.E.J. Weber, F. Dangond, V. Batra, A. Sette, D.A. Hafler, Different activation of proliferation and cytotoxicity in human T-cell lymphotrophic virus type I Tax-specific CD8 T cells by an altered peptide ligand, Proc. Natl. Acad. Sci. USA 92 (1995) 4036-4040.
16. D.-G. Lim, K. Bieganowska Bourcier, G.J. Freeman, D.A. Hafler, Examination of CD8+ T cell function in humans using MHC class I tetramers: Cytotoxicity but variable proliferation and cytokine production among different clonal CD8+ T cells specific to a single viral epitope, J. Immunol. 165 (2000) 6214-6220.
17. A. Dressel, J.L. Chin, A. Sette, R. Gausling, P. Hollsberg, D.A. Hafler, Autoantigen recognition by human CD8 T cell clones. Enhanced agonist response induced by altered peptide ligands, J. Immunol. 159 (1997) 4943-4951.
18. H. Fukaura, S.C. Kent, M.J. Pietrusewicz, S.J. Khoury, H.L. Weiner, D.A. Hafler, Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β-1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients, J. Clin. Invest. 98 (1996) 70-77.
19. K. Murali-Krishna, J.D. Altman, M. Suresh, D.J. Sourdive, A.J. Zajac, J.D. Miller, J. Slansky, R. Ahmed, Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection, Immunity 8 (1998) 177-187.
20. + T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy, J. Immunol. 162 (1999) 1765-1771.
21. N.A. Mitchison, Induction of immunological paralysis in two zones of dosage, Proc. R. Soc. London Ser. B. 161 (1964) 275-292.
22. L.A. Matis, L.H. Glimcher, W.E. Paul, R.H. Schwartz, Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules, Proc. Natl. Acad. Sci. USA 80 (1983) 6019-6023.
23. G. Suzuki, Y. Kawase, S. Koyasu, I. Yahara, Y. Kobayashi, R.H. Schwartz, Antigen-induced suppression of the proliferative response of T cell clones, J. Immunol. 140 (1988) 1359-1365.
24. J.M. Critchfield, M.K. Racke, J.C. Zuniga-Pflucker, B. Cannella, C.S. Raine, J. Goverman, M.J. Lenardo, T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis, Science 263 (1994) 1139-1143.
25. R.H. Schwartz, T cell clonal anergy, Curr. Opin. Immunol. 9 (1997) 351-357.
26. c chain of the IL-2 receptor, Science 266 (1994) 1039-1042.
27. A.D. Wells, M.C. Walsh, D. Sankaran, L.A. Turka, T cell effector function and anergy avoidance are quantitatively linked to cell division, J. Immunol. 165 (2000) 2432-2443.
28. A.D. Wells, M.C. Walsh, J.A. Bluestone, L.A. Turka, Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy, J. Clin. Invest. 108 (2001) 895-904.
29. P. Shrikant, A. Khoruts, M.F. Mescher, CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism, Immunity 11 (1999) 483-493.
30. I. Vermes, C. Haanen, C.P.M. Reutelingsperger, A novel assay for apoptosis: Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V, J. Immunol. Methods 180 (1995) 39-51.
31. F.D. Mattia, S. Chomez, F.V. Laethem, V. Moulin, J. Urbain, M. Moser, O. Leo, F. Andris, Antigen-experienced T cells undergo a transient phase of unresponsiveness following optimal stimulation, J. Immunol. 163 (1999) 5929-5936.
32. S.-M. Kang, B. Beverly, A.-C. Tran, K. Brorson, R.H. Schwartz, M.J. Lenardo, Transactivation by AP-1 is a molecular target of T cell clonal anergy, Science 257 (1992) 1134-1138.
33. W. Li, C.D. Whaley, A. Mondino, D.L. Mueller, Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells, Science 271 (1996) 1272-1276.
34. P.E. Fields, T.F. Gajewski, F.W. Fitch, Blocked Ras activation in anergic CD4+ T-cells, Science 271 (1996) 1276-1278.
35. T.F. Gajewski, D. Qian, P. Fields, F.W. Fitch, Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways, Proc. Natl. Acad. Sci. USA 91 (1994) 38-42.
36. V.A. Boussiotis, G.J. Freeman, P.A. Taylor, A. Berezovskaya, I. Grass, B.R. Blazar, L.M. Nadler, P27kip1 functions as an anergy factor inhibiting interleukin2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes, Nat. Med. 6 (2000) 290-297.
37. R.D. Cardin, J.W. Brooks, S.R. Sarawar, P.C. Doherty, Progressive loss of CD8+ T cell-mediated control of a g-herpesvirus in the absence of CD4+ T cells, J. Exp. Med. 184 (1996) 863-871.
38. M. Matloubian, R.J. Concepcion, R. Ahmed, CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection, J. Virol. 68 (1994) 8056-8063.
39. A.J. Zajac, J.N. Blattman, K. Murali-Krishna, D.J.D. Sourdive, M. Suresh, J.D. Altman, R. Ahmed, Viral immune evasion due to persistence of activated T cells effector function, J. Exp. Med. 188 (1999) 2205-2213.